Clinical trial

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

NCT04427280

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Throat/nose swabs Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Saliva collection Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Blood collection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-05-26

PhaseN/A

Conditions

Infectious Diseaseverified · MONDO: infectious disease

Cancerverified · MONDO: cancer

Coronavirus Infectionunresolved

Interventions

Throat/nose swabsDIAGNOSTIC_TEST

Saliva collectionDIAGNOSTIC_TEST

Blood collectionDIAGNOSTIC_TEST

Sponsors & collaborators

Royal Marsden NHS Foundation Trustlead sponsor

St George's, University of Londoncollaborator

Mologic Ltdcollaborator

The Royal Marsden Cancer Charitycollaborator

Nottingham Biomedical Research Centrecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04427280 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.